Elutia Inc. (ELUT): Total Assets
$62.35M
As of 2025-12-31
$43.65M
As of 2026-06-30
-3.2%
3-year compound annual growth
-5.5%
5-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $62.35M | +72.6% | 2026-03-13, Balance as of period end |
| 2024-12-31 | $36.13M | -16.8% | 2026-03-13, Balance as of period end |
| 2023-12-31 | $43.43M | -36.9% | 2025-03-11, Balance as of period end |
| 2022-12-31 | $68.84M | +2.5% | 2024-03-11, Balance as of period end |
| 2021-12-31 | $67.17M | -18.9% | 2023-03-23, Balance as of period end |
| 2020-12-31 | $82.81M | +85.0% | 2022-03-08, Balance as of period end |
| 2019-12-31 | $44.77M | n/a | 2021-03-15, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Elutia Inc. (ELUT) | 2025-12-31 | $62.35M | +72.6% |
| Passage BIO, Inc. (PASG) | 2025-12-31 | $62.28M | -39.2% |
| Cardiff Oncology, Inc. (CRDF) | 2025-12-31 | $61.88M | -36.3% |
| Sangamo Therapeutics, Inc (SGMOQ) | 2025-12-31 | $59.74M | -41.2% |
| Fennec Pharmaceuticals Inc. (FENC) | 2025-12-31 | $70.55M | +57.0% |
| Senti Biosciences Holdings, Inc. (SNTI) | 2025-12-31 | $51.22M | -47.6% |
| Armata Pharmaceuticals, Inc. (ARMP) | 2025-12-31 | $76.88M | -11.1% |
| Alpha Cognition Inc. (ACOG) | 2025-12-31 | $79.73M | +57.1% |
| Cognition Therapeutics Inc (CGTX) | 2025-12-31 | $48.39M | +60.1% |
Compare ELUT, PASG, CRDF, SGMOQ side by side · Screen every company in Biological Products, (No Diagnostic Substances) ↗